Acyclovir prophylaxis for pregnant women with a known history of herpes simplex virus: A cost-effectiveness analysis

Acyclovir prophylaxis versus no treatment for pregnant women with a diagnosed history of genital herpes simplex virus infection but without recurrence during pregnancy is cost-effective over a wide range of assumptions.